A RANDOMIZED TRIAL OF ANTICOAGULATION WITH WARFARIN AND OF ALTERNATING CHEMOTHERAPY IN EXTENSIVE SMALL-CELL LUNG-CANCER BY THE CANCER AND LEUKEMIA GROUP-B

被引：180

作者：

CHAHINIAN, AP

PROPERT, KJ

WARE, JH

ZIMMER, B

PERRY, MC

HIRSH, V

SKARIN, A

KOPEL, S

HOLLAND, JF

COMIS, RL

GREEN, MR

机构：

[1] FRONTIER SCI & TECHNOL RES FDN INC,AMHERST,NY

[2] ROYAL VICTORIA HOSP,MONTREAL H3A 1A1,QUEBEC,CANADA

[3] HARVARD UNIV,SCH MED,DANA FARBER CANC INST,BOSTON,MA 02115

[4] MAIMONIDES HOSP,DIV HEMATOL ONCOL,BROOKLYN,NY 11219

[5] CUNY MT SINAI SCH MED,DEPT NEOPLAST DIS,NEW YORK,NY 10029

[6] HARVARD UNIV,SCH PUBL HLTH,DEPT BIOSTAT,BOSTON,MA 02115

[7] UNIV MISSOURI,MED CTR,SCH MED,DEPT MED,COLUMBIA,MO 65201

[8] FOX CHASE CANC INST,PHILADELPHIA,PA 19111

[9] UNIV CALIF SAN DIEGO,DEPT MED,LA JOLLA,CA 92093

[10] UNIV CALIF SAN DIEGO,CTR CANC,LA JOLLA,CA 92093

来源：

关键词：

D O I：

10.1200/JCO.1989.7.8.993

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：993 / 1002

页数：10

共 21 条

[1] ARMITAGE P, 1971, STATISTICAL METHODS
[2] CHAHINIAN AP, 1982, B CANCER, V69, P79
[3] MITOMYCIN-C, ETOPOSIDE, CISPLATIN, AND HEXAMETHYLMELAMINE (MEPH) AS A 2ND-LINE REGIMEN IN LUNG-CANCER
CHAHINIAN, AP
GREEN, G
HOLLAND, JF
[J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1984, 7 (05): : 419 - 423
[4] COX DR, 1972, J R STAT SOC B, V34, P187
[5] CYCLIC ALTERNATING NON-CROSS RESISTANT CHEMOTHERAPY IN THE MANAGEMENT OF SMALL CELL ANAPLASTIC CARCINOMA OF THE LUNG
ELLIOTT, JA
OSTERLIND, K
HANSEN, HH
[J]. CANCER TREATMENT REVIEWS, 1984, 11 (02) : 103 - 113
[6] SUPERIORITY OF ALTERNATING NON-CROSS-RESISTANT CHEMOTHERAPY IN EXTENSIVE SMALL-CELL LUNG-CANCER - A MULTICENTER, RANDOMIZED CLINICAL-TRIAL BY THE NATIONAL-CANCER-INSTITUTE-OF-CANADA
EVANS, WK
FELD, R
MURRAY, N
WILLAN, A
COY, P
OSOBA, D
SHEPHERD, FA
CLARK, DA
LEVITT, M
MACDONALD, A
WILSON, K
SHELLEY, W
PATER, J
[J]. ANNALS OF INTERNAL MEDICINE, 1987, 107 (04) : 451 - 458
[7] GOLDIE JH, 1982, CANCER TREAT REP, V66, P439
[8] GOLDIE JH, 1984, CANCER RES, V44, P3643
[9] LIVINGSTON RB, 1986, CANCER TREAT REP, V70, P1395
[10] COMBINED MODALITY THERAPY WITH RADIOTHERAPY, CHEMOTHERAPY, AND IMMUNOTHERAPY IN LIMITED SMALL-CELL CARCINOMA OF THE LUNG - A PHASE-III CANCER AND LEUKEMIA GROUP-B STUDY
MAURER, LH
PAJAK, T
EATON, W
COMIS, R
CHAHINIAN, P
FAULKNER, C
SILBERFARB, PM
HENDERSON, E
REGE, VB
BALDWIN, PE
WEISS, R
RAFLA, S
PRAGER, D
CAREY, R
PERRY, M
CHOI, NC
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (07) : 969 - 976